The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting ... CFO David Denton said the company is already expecting a $150 million impact in 2025 from the current slate of tariffs but did ...

A number of US pharmaceutical groups have recently made announcements about expanding domestic manufacturing. These include ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer CEO Albert Bourla on Tuesday said ... the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict ...

Pfizer CEO Albert Bourla said the pharmaceutical ... the company behind fast food chains like Taco Bell and Pizza Hut, expects little impact from tariffs on its supply chain, CFO Chris Turner ...

Pfizer reaffirming its outlook for the full year but noting it has not factored in any potential impact from tariffs. Here to discuss what these results mean for the drug maker we've got Vamul Divan.

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...